Anupam Rasayan India Ltd

Anupam Rasayan Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Anupam Rasayan India Ltd

₹ 1,294 -5.42%
29 May - close price
anupamrasayan.com BSE: 543275 NSE: ANURAS
About

Anupam Rasayan India Ltd is engaged in manufacturing of specialty chemicals, which are sold in local as well as exported to other countries.[1]

Key Points

Business Verticals FY24
1) Life Science Specialty Chemicals (91%):
a. Agrochemicals (65%)- Manufactures agro intermediates and agro active ingredients (insecticides, fungicides, and herbicides) for the agrochemical industry.
b. Personal Care (17%) - Manufactures antibacterial and ultraviolet protection intermediates and ingredients for the personal care industry.
c. Pharmaceuticals (9%)- The segment focuses on developing intermediates and ‘key starting materials’ for active pharmaceutical ingredients.

Website BSE NSE
  • Market Cap ₹ 14,731 Cr.
  • Current Price ₹ 1,294
  • High / Low ₹ 1,415 / 983
  • Stock P/E 86.6
  • Book Value ₹ 293
  • Dividend Yield 0.06 %
  • ROCE 7.36 %
  • ROE 5.50 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is expected to give good quarter

Cons

  • Stock is trading at 4.42 times its book value
  • Tax rate seems low
  • Company has a low return on equity of 4.60% over last 3 years.
  • Dividend payout has been low at 6.50% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of Nifty 500 Nifty MidSmallcap 400 Nifty Smallcap 250 Nifty 500 Multicap 50:25:25 Nifty Total Market

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
480 386 392 296 401 254 294 390 500 486 731 512 636
363 285 285 216 308 201 214 266 356 362 596 385 498
Operating Profit 117 101 107 79 93 53 80 124 144 124 136 127 137
OPM % 24% 26% 27% 27% 23% 21% 27% 32% 29% 26% 19% 25% 22%
24 12 3 2 12 6 2 -4 6 5 8 2 3
Interest 20 18 20 25 26 22 27 32 31 36 36 35 42
Depreciation 19 19 20 20 21 21 22 29 31 31 32 34 43
Profit before tax 103 77 71 36 58 16 34 59 88 63 76 60 56
Tax % 29% 32% 31% 28% 30% 25% 10% 9% 29% 23% 24% -1% 0%
73 52 49 26 40 12 31 54 63 48 57 61 56
EPS in Rs 5.27 3.59 3.78 1.68 2.82 0.36 1.52 2.56 4.05 3.10 3.90 4.31 3.75
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
502 529 811 1,074 1,602 1,475 1,437 2,365
408 394 617 769 1,171 1,094 1,036 1,841
Operating Profit 93 135 194 305 431 381 401 525
OPM % 19% 25% 24% 28% 27% 26% 28% 22%
19 11 26 8 10 30 11 18
Interest 24 45 69 31 63 89 112 149
Depreciation 23 29 52 60 71 80 102 140
Profit before tax 66 72 100 222 308 242 198 254
Tax % 24% 26% 30% 31% 30% 31% 19% 13%
49 53 70 152 217 167 160 222
EPS in Rs 9.85 10.64 7.04 15.18 16.83 11.71 8.49 14.94
Dividend Payout % 0% 0% 7% 7% 15% 11% 9% 0%
Compounded Sales Growth
10 Years: %
5 Years: 24%
3 Years: 14%
TTM: 65%
Compounded Profit Growth
10 Years: %
5 Years: 19%
3 Years: -2%
TTM: 82%
Stock Price CAGR
10 Years: %
5 Years: 12%
3 Years: 5%
1 Year: 29%
Return on Equity
10 Years: %
5 Years: 6%
3 Years: 5%
Last Year: 6%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 50 50 100 100 107 110 110 146
Reserves 432 515 1,473 1,627 2,265 2,651 2,740 3,188
694 847 423 836 822 1,069 1,373 1,867
146 252 301 327 584 772 1,045 2,811
Total Liabilities 1,323 1,664 2,298 2,891 3,778 4,602 5,269 8,013
681 977 1,115 1,202 1,417 1,501 2,185 3,713
CWIP 191 101 43 44 120 609 216 114
Investments 0 0 0 149 67 67 9 19
451 586 1,140 1,496 2,173 2,424 2,860 4,167
Total Assets 1,323 1,664 2,298 2,891 3,778 4,602 5,269 8,013

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
39 95 1 -171 292 59 -30 334
-250 -178 -193 -412 -523 -392 -330 -820
206 102 416 384 371 395 223 621
Net Cash Flow -6 19 224 -199 140 62 -137 135
Free Cash Flow -209 -85 -144 -318 232 -644 -440 -220
CFO/OP 55% 77% 10% -44% 84% 28% 3% 72%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 88 89 92 95 95 143 186 148
Inventory Days 277 515 530 852 483 627 876 490
Days Payable 105 226 215 225 167 247 348 261
Cash Conversion Cycle 260 379 408 722 410 524 715 377
Working Capital Days 56 21 168 218 153 138 160 111
ROCE % 9% 10% 11% 13% 9% 7% 7%

Insights

In beta
Mar 2017 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of Manufacturing Units
Number ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Installed Production Capacity
MTPA
Number of Commercialized Molecules
Number
Number of Customers (MNCs)
Number
Molecules in R&D Pipeline
Number
Tanfac Industries - Hydrofluoric Acid (HF) Capacity
MTPA ・Standalone data
R&D Expenditure (Percentage of Turnover)
% ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
60.77% 60.73% 61.41% 61.26% 61.23% 61.23% 61.19% 61.19% 61.19% 59.07% 59.07% 59.07%
9.79% 10.26% 9.13% 8.07% 7.14% 7.00% 7.46% 6.47% 4.94% 7.63% 7.60% 6.91%
3.74% 1.76% 2.51% 2.56% 2.56% 2.30% 2.32% 2.25% 2.24% 1.37% 0.41% 0.35%
25.71% 27.25% 26.96% 28.10% 29.06% 29.47% 29.06% 30.11% 31.65% 31.93% 32.89% 33.65%
No. of Shareholders 61,50461,12960,08957,62362,21863,86660,93857,47847,71148,78547,46943,475

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls